Deep Vein Thrombosis

Clinical Trial Finder

Many patients with deep vein thrombosis are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

General Practitioner-performed Compression Ultrasound for Deep Vein Thrombosis

Condition:   Deep Vein Thrombosis
Intervention:   Other: compression ultrasonography
Sponsor:   Azienda Sanitaria Locale ASL 6, Livorno
Not yet recruiting - verified April 2014

Venous Thrombectomy/Thrombolysis Outcome Registry

Conditions:   Deep Venous Thrombosis;   Post Thrombotic Syndrome
Intervention:  
Sponsor:   Heart and Vascular Outcomes Research Institute
Active, not recruiting - verified April 2014

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Conditions:   Pulmonary Embolism;   Thromboembolism;   Thrombosis;   Venous Thrombosis;   Venous Thromboembolism
Interventions:   Drug: BAY 59-7939;   Drug: BAY 59-7939;   Drug: ASA
Sponsor:   Bayer
Recruiting - verified April 2014

The Designer D-dimer Deep Vein Thrombosis Diagnosis (4D) Study

Condition:   Suspected Deep Vein Thrombosis
Intervention:  
Sponsors:   McMaster University;   Canadian Institutes of Health Research (CIHR)
Recruiting - verified April 2014

AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients

Conditions:   Deep Vein Thrombosis;   Pulmonary Embolism
Interventions:   Drug: Apixaban;   Drug: Unfractionated Heparin (UFH);   Drug: Warfarin
Sponsors:   Pfizer;   Bristol-Myers Squibb
Active, not recruiting - verified April 2014

ARIXTRA® Adherence in SVT Patients.

Condition:   Thrombosis, Venous
Intervention:   Drug: Fondaparinux
Sponsor:   GlaxoSmithKline
Active, not recruiting - verified April 2014

The 36-month Extension to Follow up Sub Study

Conditions:   Postphlebitic Syndrome;   Post-Thrombotic Syndrome;   Deep Vein Thrombosis
Intervention:  
Sponsors:   Sir Mortimer B. Davis - Jewish General Hospital;   Canadian Institutes of Health Research (CIHR);   Heart and Stroke Foundation of Canada;   Sigvaris Corporation
Active, not recruiting - verified April 2014

The Side of Implantable Central Vascular Catheters and Complications

Condition:   Upper Extremity Deep Vein Thrombosis, Secondary
Intervention:  
Sponsor:   National Taiwan University Hospital
Recruiting - verified April 2014

Post-authorization Safety Study of Etoricoxib and Other Anti-inflammatory Therapies in European Patients With Ankylosing Spondylitis (MK-0663-163)

Condition:   Ankylosing Spondylitis
Intervention:  
Sponsor:   Merck Sharp & Dohme Corp.
Active, not recruiting - verified April 2014

Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism

Condition:   Venous Thrombosis
Interventions:   Drug: Enoxaparin;   Drug: warfarin;   Drug: Placebo for apixaban;   Drug: Placebo for enoxaparin;   Drug: Placebo for warfarin;   Drug: apixaban
Sponsors:   Bristol-Myers Squibb;   Pfizer
Completed - verified April 2014

Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)

Conditions:   Deep Vein Thrombosis of Lower Limb;   Pulmonary Embolism (PE);   Bleeding
Interventions:   Device: ActiveCare CECT device;   Drug: Enoxaparin
Sponsor:   Medical Compression Systems
Completed - verified February 2010

Get CardioSmart

You're Invited